Severe neutropenia in children: A single institutional experience

Journal of Pediatric Hematology/Oncology

Volumn 29, Issue 8, 2007, Pages 513-518

  Yilmaz, Deniz ^a,c   Ritchey, Arthur Kim ^b  

^a EGE UNIVERSITY   (Turkey)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c NONE   (Turkey)

Author keywords

Child; Filgrastim; Severe neutropenia

Indexed keywords

CORTICOSTEROID; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEROID;

ADOLESCENT; ARTICLE; AUTOIMMUNE DISEASE; CHILD; CLINICAL ARTICLE; CONVALESCENCE; DOCUMENTATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EXPERIENCE; FAMILIAL DISEASE; FEMALE; FOLLOW UP; HISTORY; HOSPITALIZATION; HUMAN; IDIOPATHIC DISEASE; INFANT; INFECTION; INSTITUTIONAL CARE; MALE; NEUTROPENIA; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; SEPSIS; UNIVERSITY HOSPITAL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FILGRASTIM; HUMANS; INFANT; MALE; NEUTROPENIA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34548426927     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3180f61b26     Document Type: Article

References (16)

1. Dale DC, Bonilla MA, Davis MW, et al. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (Filgrastim) for treatment of severe chronic neutropenia. Blood. 1993;81:2496-2502.
2. Palmblad J, Papadaki HA, Eliopoulos G. Acute and chronic neutropenias. What is new? J Int Med. 2001;250:476-491.
3. Stevens RF. Disorders of granulopoiesis and granulocyte function. In: Lilleyman J, Hann I, Blanchette V, eds. Pediatric Hematology. 2nd ed. China: Churchill-Livingstone; 1999:331-353.
4. Dale DC, Cottle TE, Fier CJ, et al. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am J Hematol. 2003;72:82-93.
5. Jonsson OG, Buchanan GR. Chronic Neutropenia during childhood: a 13 year experience in a single institution. Am J Dis Child. 1991;145:232-235.
6. Bux J, Behrens G, Jaeger G, et al. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood. 1998;91:181-186.
7. Kobayashi M, Nakamura K, Kawaguchi H, et al. Significance of the detection of antineutrophil antibodies in children with chronic neutropenia. Blood. 2002;99:3468-3471.
8. Donadieu J, Boutard P, Bernotowska E, et al. for the Lenogastrim study group. A European phase II study of recombinant human granulocyte colony stimulating factor (lenogastrim) in the treatment of severe chronic neutropenia in children. Eur J Pediatr. 1997;156:693-700.
9. Welte K, Zeidler C, Reiter A, et al. Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. Blood. 1990;75:1056-1063.
10. Bonilla AM, Gillio AP, Ruggeiro M, et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Eng J Med. 1989;320:1574-1580.
11. Bolyard JE, Dale D. Quality of life of patients with chronic neutropenia receiving long term treatment with granulocyte colony stimulating factor. JAMA. 1993;270:1132-1133.
12. Bruin MCA, von dem Borne AEG, Tamminga RYJ, et al. Neutrophil antibody specificity in different types of childhood autoimmune neutropenia. Blood. 1999;94:1797-1802.
13. Leung TF, Li CK, Kwok KL, et al. Severe chronic neutropenia in Chinese children in Hong Kong. J Paediatr Child Health. 2001;37:137-141.
14. Karlström R, Gustafsson R, Palmblad J. Chronic mild neutropenias in adults-relation to IgG3 deficiency and infection susceptibility. J Intern Med. 2001;250:342-347.
15. Bernini JC, Wooley R, Buchanan GR. Low dose recombinant human granulocyte colony-stimulating factor therapy in children with symptomatic chronic idiopathic neutropenia. J Pediatrics. 1996;129:551-558.
16. Chung BHY, Chan GCF, Lee TL, et al. Chronic benign neutropenia among Chinese children. Hong Kong Med J. 2004;10:231-236.